08:35 AM EST, 03/04/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Tuesday that Chief Financial Officer Anthony Doyle intends to resign from the company, effective April 9.

BioCryst said Doyle's resignation is not the result of any disagreement with the company on any matter relating to operations, policies, or practices.

The company said it is now searching for a new CFO and that Doyle will remain in his role through April 9 to ensure a smooth transition.

BioCryst shares were down 3.6% in recent premarket trading.